• 8891_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8857_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8754_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8720_Labor_Versameb_Forschung_II

Versameb – transforming mRNA therapies in regenerative medicine

company

Versameb is a Swiss biopharmaceutical company developing innovative local mRNA treatments in regenerative medicine and beyond.

products

Versameb has achieved preclinical proof of concept in different injury models by showing a significant acceleration of tissue regeneration after injuries.

technology

Versameb has a novel proprietary technology platform for enhanced therapeutic benefit through local mRNA treatment.

news

December 2018 | Versameb Ltd raises CHF 5.3 million for the development of mRNA therapies in regenerative medicine